Selma, Baby Boy .
HRN: 21-94-91 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/21/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/21/2022
09/28/2022
IVT
45mg
Q24H
PSNB Sec To Maternal UTI
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes